SCHEMBL18871763

SCHEMBL18871763

CCOC(=O)c1ccc(-c2ccc3c(c2)CC[C@H](C)N3C)nc1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PDK1 Q15118 13/20 0.44
▸ PDK2 Q15119 13/20 0.44
▸ PDK3 Q15120 13/20 0.44
▸ PDK4 Q16654 13/20 0.44
▸ NPC1 O15118 1/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ SENP8 Q96LD8 1/20 0.40
▸ SENP7 Q9BQF6 1/20 0.40
▸ SENP6 Q9GZR1 1/20 0.40
▸ DRD3 P35462 1/20 0.39
▸ SRD5A1 P18405 1/20 0.39
▸ SRD5A2 P31213 1/20 0.39
▸ CYP19A1 P11511 2/20 0.38
▸ FDFT1 P37268 1/20 0.38
▸ HRH3 Q9Y5N1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18871762 0.88 PDK1 (0.49) PDK1PDK2PDK3PDK4
SCHEMBL6134120 0.78 NPC1 (0.46) NPC1CASP3RAB9AATMSENP8
SCHEMBL18871979 0.77 PDK1 (0.51) PDK1PDK2PDK3PDK4
SCHEMBL18871831 0.74 PDK1 (0.49) PDK1PDK2PDK3PDK4NPC1
SCHEMBL18871982 0.73 PDK1 (0.55) PDK1PDK2PDK3PDK4
SCHEMBL11666685 0.71 HSD17B2 (0.59) NPC1RAB9A
SCHEMBL29800427 0.71 CA12 (0.56) NPC1RAB9A
SCHEMBL811649 0.71 CA12 (0.56) NPC1RAB9A
SCHEMBL20429116 0.71 PDK1 (0.51) PDK1PDK2PDK3PDK4
SCHEMBL6133955 0.69 HDAC8 (0.53) NPC1CASP3RAB9AATMSENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3168213-B1 TETRAHYDROQUINOLINE DERIVATIVES USEFUL AS BROMODOMAIN INHIBITORS GLAXOSMITHKLINE LLC (US) 2018-08-01 — — EP disclosed
EP-3168213-A1 TETRAHYDROQUINOLINE DERIVATIVES USEFUL AS BROMODOMAIN INHIBITORS Glaxosmithkline LLC (US) 2017-05-17 — — EP disclosed
Send feedback